Systematic Review on Liuweiwuling Tablets Combined with Nucleotide Analogues in Treatment of Chronic Hepatitis BΔ
Xuan HE,Yuxue YANG,Jianxia WEN,Yanling ZHAO,Lu ZHANG,Houqin ZHOU,Yang LI,Xiaohua LU,Feng HUANG
DOI: https://doi.org/10.14009/j.issn.1672-2124.2017.01.001
2017-01-01
Abstract:OBJECTIVE:To systematically evaluate the efficacy of Liuweiwuling tablets combined with nucleotide analogues in treatment of chronic hepatitis B .METHODS: Cochrane systemic evaluation method was adopted , VIP database, CNKI, Wangfang database , PubMed, Cochrane were searched up from establishment to July 2016 to find the randomized controlled trials of nucleotide analogues combined with Liuweiwuling tablet in treatment of chronic hepatitis B.The control group were treated with one drug of entecavir , adefovir dipivoxil , lamivudine and telbivudine;while the observation group were additionally treated with Liuweiwuling tablets .Screening and data extraction were conducted by researchers literature , and Meta-analysis with RevMan 5.0.RESULTS: 17 literatures were involved including 1 795 patients;among which 935 cases in observation group and 860 cases in control group .According to Meta-analysis , compared with the control group , the clinical symptoms can be improved by the regimen in observation group by reducing alanine aminotransferase , aspartate amino transferase and total bilirubin level , increasing normalization rate of alanine aminotransferase , negative rate of chronic hepatitis B DNA and hepatitis B virus E-antigen.CONCLUSIONS:Compared with the single treatment of nucleotide analogues , the efficacy of Liuweiwuling tablets combined with nucleotide analogues in treatment of chronic hepatitis B is better in improving clinical symptoms , liver function and antiviral .